Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Christopher I Johnston

Showing results (1-10 of 7) with videos related to

Pageof 1
Sort By:
Clinical Toxicology (Philadelphia, Pa.)|November 6, 2020
Australian snakebite myotoxicity (ASP-23)Christopher I Johnston, Geoffrey K Isbister
Frontiers in Pharmacology|April 7, 2022
Australian Sea Snake Envenoming Causes Myotoxicity and Non-Specific Systemic Symptoms - Australian Snakebite Project (ASP-24)Christopher I Johnston, Theo Tasoulis, Geoffrey K Isbister
Clinical Toxicology (Philadelphia, Pa.)|May 28, 2024
Investigating skeletal muscle biomarkers for the early detection of Australian myotoxic snake envenoming: an animal model pilot studyChristopher I Johnston, Anjana Silva, Wayne Hodgson, et al.
Clinical Toxicology (Philadelphia, Pa.)|December 2, 2016
Australian taipan (Oxyuranus spp.) envenoming: clinical effects and potential benefits of early antivenom therapy - Australian Snakebite Project (ASP-25)Christopher I Johnston, Nicole M Ryan, Margaret A O'Leary, et al.
Pathology|July 1, 2014
Comparative sensitivity of commercially available aPTT reagents to mulga snake (Pseudechis australis) venomLisa F Lincz, Fiona E Scorgie, Christopher I Johnston, et al.
The Medical Journal of Australia|August 3, 2017
The Australian Snakebite Project, 2005-2015 (ASP-20)Christopher I Johnston, Nicole M Ryan, Colin B Page, et al.
Plos Neglected Tropical Diseases|October 3, 2012
Death adder envenoming causes neurotoxicity not reversed by antivenom--Australian Snakebite Project (ASP-16)Christopher I Johnston, Margaret A O'Leary, Simon G A Brown, et al.
Pageof 1

Showing results (1-10 of 7) with videos related to

Sort By:
Pageof 1
Clinical Toxicology (Philadelphia, Pa.)|November 6, 2020
Australian snakebite myotoxicity (ASP-23)Christopher I Johnston, Geoffrey K Isbister
Frontiers in Pharmacology|April 7, 2022
Australian Sea Snake Envenoming Causes Myotoxicity and Non-Specific Systemic Symptoms - Australian Snakebite Project (ASP-24)Christopher I Johnston, Theo Tasoulis, Geoffrey K Isbister
Clinical Toxicology (Philadelphia, Pa.)|May 28, 2024
Investigating skeletal muscle biomarkers for the early detection of Australian myotoxic snake envenoming: an animal model pilot studyChristopher I Johnston, Anjana Silva, Wayne Hodgson, et al.
Clinical Toxicology (Philadelphia, Pa.)|December 2, 2016
Australian taipan (Oxyuranus spp.) envenoming: clinical effects and potential benefits of early antivenom therapy - Australian Snakebite Project (ASP-25)Christopher I Johnston, Nicole M Ryan, Margaret A O'Leary, et al.
Pathology|July 1, 2014
Comparative sensitivity of commercially available aPTT reagents to mulga snake (Pseudechis australis) venomLisa F Lincz, Fiona E Scorgie, Christopher I Johnston, et al.
The Medical Journal of Australia|August 3, 2017
The Australian Snakebite Project, 2005-2015 (ASP-20)Christopher I Johnston, Nicole M Ryan, Colin B Page, et al.
Plos Neglected Tropical Diseases|October 3, 2012
Death adder envenoming causes neurotoxicity not reversed by antivenom--Australian Snakebite Project (ASP-16)Christopher I Johnston, Margaret A O'Leary, Simon G A Brown, et al.
Pageof 1